Difficulty: Medium
Average Score: 94%
Practice
A 62-year-old man with congestive heart failure has been taking a loop diuretic to reduce peripheral edema. His labs today reveal low potassium. Which of the following diuretics would be better to use in this patient?
Correct answer
C
Rationale
In this scenario, the most appropriate diuretic for the 62-year-old man with congestive heart failure who is experiencing low potassium due to his loop diuretic therapy is Triamterene (Option C). Triamterene is a potassium-sparing diuretic that works in the collecting ducts of the kidney to promote sodium excretion while conserving potassium. This is crucial in this case to help prevent further potassium depletion which can be detrimental, especially in patients with heart failure who are already at risk for cardiac arrhythmias.
Option A, Acetazolamide, is a carbonic anhydrase inhibitor diuretic that is not suitable for this patient as it works in the proximal convoluted tubule and is not effective in treating the potassium imbalance caused by loop diuretics.
Option B, Ethacrynic acid, is a loop diuretic like the one the patient is already taking, and its use can further exacerbate potassium loss, worsening the current situation.
Option D, Methazolamide, is a carbonic anhydrase inhibitor like Acetazolamide and would not address the potassium imbalance in this patient.
Educationally, understanding the different classes of diuretics and their mechanisms of action is crucial for healthcare providers to make informed decisions in managing patients with conditions like heart failure. It is essential to consider the patient's electrolyte status and comorbidities when selecting the most appropriate diuretic therapy to optimize outcomes while minimizing adverse effects.
Option A, Acetazolamide, is a carbonic anhydrase inhibitor diuretic that is not suitable for this patient as it works in the proximal convoluted tubule and is not effective in treating the potassium imbalance caused by loop diuretics.
Option B, Ethacrynic acid, is a loop diuretic like the one the patient is already taking, and its use can further exacerbate potassium loss, worsening the current situation.
Option D, Methazolamide, is a carbonic anhydrase inhibitor like Acetazolamide and would not address the potassium imbalance in this patient.
Educationally, understanding the different classes of diuretics and their mechanisms of action is crucial for healthcare providers to make informed decisions in managing patients with conditions like heart failure. It is essential to consider the patient's electrolyte status and comorbidities when selecting the most appropriate diuretic therapy to optimize outcomes while minimizing adverse effects.